Morbidity and utilisation of healthcare services among people with cardiometabolic disease in three diverse regions of rural India.


Journal

Chronic illness
ISSN: 1745-9206
Titre abrégé: Chronic Illn
Pays: United States
ID NLM: 101253019

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 27 11 2023
pubmed: 7 2 2023
entrez: 6 2 2023
Statut: ppublish

Résumé

To assess the prevalence and determinants of cardiometabolic disease (CMD), and the factors associated with healthcare utilisation, among people with CMD. Using a cross-sectional design, 11,657 participants were recruited from randomly selected villages in 3 regions located in Kerala and Andhra Pradesh from 2014 to 2016. Multivariable logistic regression was used to identify factors independently associated with CMD and healthcare utilisation (public or private). Thirty-four per cent (n = 3629) of participants reported having ≥1 CMD, including hypertension (21.6%), diabetes (11.6%), heart disease (5.0%) or chronic kidney disease (CKD) (1.6%). The prevalence of CMD was progressively greater in regions of greater socio-economic position (SEP), ranging from 19.1% to 40.9%. Among those with CMD 41% had sought any medical advice in the last month, with only 19% utilising public health facilities. Among people with CMD, those with health insurance utilised more healthcare (age-gender adjusted odds ratio (AOR) (95% confidence interval (CI)): 1.31 (1.13, 1.51)) as did those who reported accessing private rather than public health services (1.43 (1.23, 1.66)). The prevalence of CMD is high in these regions of rural India and is positively associated with indices of SEP. The utilisation of outpatient health services, particularly public services, among those with CMD is low.

Identifiants

pubmed: 36744377
doi: 10.1177/17423953231153550
pmc: PMC10655594
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

873-888

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Int J Obes Relat Metab Disord. 2001 Nov;25(11):1722-9
pubmed: 11753596
Soc Sci Med. 2019 Dec;243:112634
pubmed: 31698205
J Am Heart Assoc. 2020 Apr 7;9(7):e014486
pubmed: 32223389
Indian J Med Res. 2015 Apr;141(4):438-45
pubmed: 26112845
BMJ Open. 2016 Oct 8;6(10):e012404
pubmed: 27855099
Health Informatics J. 2008 Dec;14(4):309-21
pubmed: 19008280
Am J Epidemiol. 1993 Dec 1;138(11):923-36
pubmed: 8256780
Eur J Public Health. 2019 Feb 1;29(1):88-93
pubmed: 30016426
Int J Epidemiol. 2012 Oct;41(5):1302-14
pubmed: 22345313
Lancet. 2017 Dec 2;390(10111):2437-2460
pubmed: 29150201
J Fam Pract. 2000 Feb;49(2):147-52
pubmed: 10718692
Indian J Community Med. 2018 Jul-Sep;43(3):141-143
pubmed: 30294075
Int J Health Policy Manag. 2014 Jan 06;2(1):29-38
pubmed: 24596902
Int J Health Policy Manag. 2016 Nov 02;6(1):5-8
pubmed: 28005537
PLoS Med. 2005 May;2(5):e133
pubmed: 15916467
Lancet. 2011 Feb 5;377(9764):505-15
pubmed: 21227492
BMC Med Res Methodol. 2013 Jul 16;13:92
pubmed: 23855337
J Hypertens. 2021 Jan;39(1):107-116
pubmed: 32833918
BMC Health Serv Res. 2013 Aug 13;13:306
pubmed: 23938172
BMJ Open. 2012 Jul 18;2(4):
pubmed: 22815470
Diabetologia. 2011 Dec;54(12):3022-7
pubmed: 21959957
Health Econ Policy Law. 2014 Oct;9(4):359-82
pubmed: 24661805
Bull World Health Organ. 2012 Sep 1;90(9):685-92
pubmed: 22984313
PLoS One. 2013 Jul 16;8(7):e69170
pubmed: 23874904
PLoS One. 2014 Dec 03;9(12):e110262
pubmed: 25470732
Lancet Diabetes Endocrinol. 2017 Aug;5(8):585-596
pubmed: 28601585

Auteurs

Sojib Bin Zaman (SB)

Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia.

Roger G Evans (RG)

Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Physiology, Monash University, Melbourne, Australia.
Pre-clinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.

Clara K Chow (CK)

George Institute for Global Health, University of New South Wales, Sydney, Australia.
Department of Cardiology, Westmead Hospital, Sydney, Australia.

Rohina Joshi (R)

George Institute for Global Health, University of New South Wales, Sydney, Australia.
Sydney Medical School, University of Sydney, Sydney, Australia.
George Institute for Global Health, New Delhi, India.

Kavumpurathu R Thankappan (KR)

Public Health and Community Medicine, Central University of Kerala, Kasaragod, India.

Brian Oldenburg (B)

Non-Communicable Diseases and Implementation Science, Baker Heart and Diabetes Institute, Melbourne, Australia.

Ajay S Mahal (AS)

Nossal Institute for Global Health, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.

Kartik Kalyanram (K)

Rishi Valley Rural Health Centre, Chittoor District, India.

Kamakshi Kartik (K)

Rishi Valley Rural Health Centre, Chittoor District, India.

Michaela A Riddell (MA)

Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia.

Oduru Suresh (O)

Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia.
Rishi Valley Rural Health Centre, Chittoor District, India.

Nihal Thomas (N)

Department of Endocrinology, Diabetes & Metabolism, Christian Medical College, Vellore, India.

Gomathyamma K Mini (GK)

Global Institute of Public Health, Ananthapuri Hospitals and Research Institute, Trivandrum, India.

Pallab K Maulik (PK)

George Institute for Global Health, University of New South Wales, Sydney, Australia.
George Institute for Global Health, New Delhi, India.

Velandai K Srikanth (VK)

Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia.
Peninsula Clinical School, Central Clinical School, Monash University, Frankston, Australia.

Amanda G Thrift (AG)

Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH